期刊文献+

(C+N)复合强化的Fe-Cr-Mn(W,V)钢高温性能的研究 被引量:3

RESEARCH ON THE HIGH TEMPERATURE STRENGTH AND DUCTILITY OF(C+N)COMPLEX STRENGTHENING Fe-Cr-Mn(W,V) STEELS
下载PDF
导出
摘要 研究了用于核反应堆低放射性结构材料 Fe- Cr- Mn( W,V)奥氏体钢。通过 ( C+ N)复合强化有效地提高 Fe- 1 2 % Cr- 1 5% Mn( W,V)钢高温强度和蠕变断裂寿命 ,并改善高温塑性。在温度 673K以下 ,该合金比 SUS31 6钢和 JPCAS钢强度和塑性优良。合金强度和塑性与形变温度的相互关系是和合金形变组织变化密切相关。对 673K以上塑性降低的原因进行断口和显微组织分析 ,控制晶界碳化物粗化是进一步提高高温塑性的主要途径。 The Fe Cr Mn(W,V)austenitic steels as a low radio active structural material have been studied The high temperature strength,high temperature ductility and creep rupture life of the material Fe 12Cr 15Mn(W,V)steels can be improved with(C+N)complex strengthening of these alloys are superior to SUS316 steel and JPCAS steel below temperature 673 K in terms of high temperature strength and ductility The relationship between the strength,ductility and the deformation temperature is related to the evolution of deformation microstructure In order to explain the decreased ductility above 673 K,the fracture and microstructure were observed To control the coarse carbides at grain boundaries is very effective for improvement of high temperature ductility
出处 《钢铁》 CAS CSCD 北大核心 2000年第3期46-51,共6页 Iron and Steel
关键词 Fe-Cr-Mn钢 高温强度 形变马氏体 层错 复合强化 Fe Cr Mn steel, high temperature strength,deformation martensite,stacking faults
  • 相关文献

参考文献2

  • 1张学武,姚海红,梅轶芳,王辉,高娟,林志国,张海宏,王言,赵彦萍,王亮,李洋,李英楠,聂英坤,徐亮,舒强,刘花香,李向培,厉小梅,徐晋,刘璘琛,王艳艳,沈友轩,冷晓梅,吴庆军,王立,赵岩,丁进,李治琴,牛敏,冯媛,陈倩蕴,冷南,王聪华,刘湘源,王芳,王秀娟,张舸,刘宏潇,周惠琼,王丽英,赵千子,李胜光,段婷,周明珠,赵义,黄彦弘,路跃武,黄桂芬,韩峰,戚务芳,张娜,董笑影,孙文闻,高丽霞,王俊祥,陈海英,顾光,李芳,姜国平,刘涛,王晋平,陈雁飞,王晓云,刘斌,李法新,夏丽萍,张榕,赵丽娟,张冶宇,郭韵,薛江霞,刘冬梅,王岩岩,戴冰冰,刘伟,刘畅,华冰珠,丁从珠,顾菲,孙怡宁,莫凌菲,张斌,宁旺斌,潘静,沈凌汛,连莉,黄文辉,林泽英.全国多中心使用糖皮质激素风湿病患者骨质疏松调查[J].中华临床免疫和变态反应杂志,2017,11(3):277-284. 被引量:29
  • 2纪宗斐,张卓君,鲍春德,赵东宝,林进,吴华香,何东仪,杜红卫,姜林娣.糖皮质激素相关骨质疏松的流行病学调查[J].中华风湿病学杂志,2014,18(8):520-524. 被引量:20

二级参考文献13

  • 1Compston J. Management of glucocorticoid-induced osteoporosis [J]. Nature Rev Rheumatol, 2010, 6: 82-88.
  • 2Grossman JM, Gordon R, Ranganath VK, et al. American College of Rheumatology 2010 recommendations for the pre- vention and treatment of glucocortieoid-induced osteoporosis[J]. Arthritis Care Res, 2010, 62: 1515-1526.
  • 3陈智颖,福州城镇社区女性绝经前后诸证的证素特点研究[D].福建:福建中医药大学,2012.
  • 4中华医学会骨质疏松和骨矿盐疾病分会.原发性骨质疏松症诊治指南[J].中华医学会骨质疏松和骨矿盐杂志,2011,4:2.17.
  • 5Lekamwasam AS, Adachi JD, Agnusdei D, et al. A framework for the development of guidelines for the management of gluco- cortieoid induced osteoporosis[J]. Osteoporos Int, 2012, 23: 2257-2276.
  • 6Yeap SS, Fauzi AR, Kong NC, et al. A comparison of calcium, calcitriol, and alendronate in corticostemid-treated premeno- pausal patients with systemic lupus erythematosus[J]. J Rheuma- tol, 2008, 35: 2344-2347.
  • 7Okada Y, Nawata M, Nakayamada S, et al. Alendronate protects premenopausal women from bone loss and fracture associated with high-dose glucocorticoid therapy [J]. J Rheumatol, 2008, 35 : 2249-2254.
  • 8Kikuchi Y, lmakiire T, Yamada M, et al. Effect of risedronate on high-dose corticosteroid-induced bone loss in patients with glomerular disease[J]. Nephrol Dial Transplant, 2007, 22: 1593- 1600.
  • 9叶华.糖皮质激素所致的骨质疏松症值得重视[J].中国处方药,2008,7(9):70-71. 被引量:3
  • 10张学武.2010年美国风湿病学会最新糖皮质激素诱导的骨质疏松共识备受关注[J].中华风湿病学杂志,2011,15(3):145-146. 被引量:21

共引文献42

同被引文献15

引证文献3

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部